Report generated from Joint Formulary provided by FormularyComplete ( Accessed TA Number

Size: px
Start display at page:

Download "Report generated from Joint Formulary provided by FormularyComplete (www.pharmpress.com). Accessed TA Number"

Transcription

1 Report generated from Joint Formulary provided by FormularyComplete ( Accessed Title Formulary Status Section TA Number TA Link Annotation ALUMINIUM HYDROXIDE Aluminium-only Alu-Cap Co-magaldrox Maalox Mucogel None simeticone->aluminium- and magnesium-containing antacids simeticone->aluminium- and magnesium-containing antacids->aluminium HYDROXIDE simeticone->aluminium- and magnesium-containing antacids->aluminium HYDROXIDE->Aluminium-only simeticone->aluminium- and magnesium-containing antacids->aluminium HYDROXIDE simeticone->aluminium- and magnesium-containing antacids->aluminium HYDROXIDE->Co-magaldrox simeticone->aluminium- and magnesium-containing antacids->aluminium HYDROXIDE->Co-magaldrox

2 MAGNESIUM CARBONATE Aromatic Magnesium Carbonate Mixture, BP MAGNESIUM TRISILICATE Magnesium Trisilicate Tablets, Compound, BP Magnesium Trisilicate Mixture, BP Aluminium-magnesium complexes HYDROTALCITE With simeticone Altacite Plus simeticone->aluminium- and magnesium-containing antacids simeticone->aluminium- and magnesium-containing antacids->magnesium CARBONATE simeticone->aluminium- and magnesium-containing antacids simeticone->aluminium- and magnesium-containing antacids->magnesium TRISILICATE simeticone->aluminium- and magnesium-containing antacids->magnesium TRISILICATE simeticone simeticone->aluminium-magnesium complexes simeticone->aluminium-magnesium complexes->hydrotalcite simeticone->aluminium-magnesium complexes->hydrotalcite->with simeticone

3 Antacid containing simeticone Altacite Plus Maalox Plus Simeticone alone Dentinox Infacol Acidex Gaviscon Peptac simeticone simeticone->antacid containing simeticone simeticone->antacid containing simeticone simeticone simeticone->simeticone alone simeticone->simeticone alone reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Alginate raft-forming oral suspensions reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Alginate raft-forming oral suspensions reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Alginate raft-forming oral suspensions

4 Gastrocote reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Other compound alginate Gaviscon Advance reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Other compound alginate Gaviscon Infant reflux disease->1.1.2 Compound alginates and proprietary indigestion ->Other compound alginate ATROPINE SULFATE gut motility->antimuscarinics Atropine gut motility->antimuscarinics->atropine SULFATE DICYCLOVERINE HYDROCHLORIDE None gut motility->antimuscarinics Dicycloverine gut motility->antimuscarinics->dicycloverine HYDROCHLORIDE Compound gut motility->antimuscarinics->dicycloverine HYDROCHLORIDE Kolanticon gut motility->antimuscarinics->dicycloverine HYDROCHLORIDE->Compound HYOSCINE BUTYLBROMIDE gut motility->antimuscarinics Parenteral hyoscine butylbromide has not been approved for.

5 Buscopan gut motility->antimuscarinics->hyoscine BUTYLBROMIDE Parenteral hyoscine butylbromide has not been approved for. PROPANTHELINE BROMIDE gut motility->antimuscarinics Pro-Banthine gut motility->antimuscarinics->propantheline BROMIDE ALVERINE CITRATE gut motility->other antispasmodics Spasmonal gut motility->other antispasmodics->alverine CITRATE MEBEVERINE HYDROCHLORIDE None gut motility->other antispasmodics Mebeverine Hydrochloride First line formulary gut motility->other antispasmodics->mebeverine HYDROCHLORIDE Mebeverine oral suspension has not been approved for. If a liquid preparation of an antispasmodic is required, use dicycloverine liquid Colofac First line formulary gut motility->other antispasmodics->mebeverine HYDROCHLORIDE Modified release gut motility->other antispasmodics->mebeverine HYDROCHLORIDE Colofac MR gut motility->other antispasmodics->mebeverine HYDROCHLORIDE->Modified release Compound gut motility->other antispasmodics->mebeverine HYDROCHLORIDE

6 Fybogel Mebeverine PEPPERMINT OIL Colpermin Mintec Test for Helicobacter pylori diabact UBT Helicobacter Test INFAI Pylobactell CIMETIDINE Cimetidine Tagamet FAMOTIDINE Famotidine gut motility->other antispasmodics->mebeverine HYDROCHLORIDE->Compound gut motility->other antispasmodics gut motility->other antispasmodics->peppermint OIL gut motility->other antispasmodics->peppermint OIL protectants->helicobacter pylori infection protectants->helicobacter pylori infection->test for Helicobacter pylori protectants->helicobacter pylori infection->test for Helicobacter pylori protectants->helicobacter pylori infection->test for Helicobacter pylori protectants->1.3.1 H2-receptor antagonists protectants->1.3.1 H2-receptor antagonists->cimetidine protectants->1.3.1 H2-receptor antagonists->cimetidine protectants->1.3.1 H2-receptor antagonists protectants->1.3.1 H2-receptor antagonists->famotidine

7 NIZATIDINE protectants->1.3.1 H2-receptor antagonists Nizatidine protectants->1.3.1 H2-receptor antagonists->nizatidine RANITIDINE protectants->1.3.1 H2-receptor antagonists Ranitidine injection should only be prescribed in secondary care by or under the explicit direction of a specialist. Ranitidine protectants->1.3.1 H2-receptor antagonists->ranitidine Ranitidine injection should only be prescribed in secondary care by or under the explicit direction of a specialist. Zantac protectants->1.3.1 H2-receptor antagonists->ranitidine Prescribe generically Ranitidine injection should only be prescribed in secondary care by or under the explicit direction of a specialist. Selective antimuscarinics protectants TRIPOTASSIUM DICITRATOBISMUTHATE protectants->1.3.3 Chelates and complexes De-Noltab protectants->1.3.3 Chelates and complexes->tripotassium DICITRATOBISMUTHATE SUCRALFATE protectants->1.3.3 Chelates and complexes Antepsin protectants->1.3.3 Chelates and complexes->sucralfate Prostaglandin analogues protectants MISOPROSTOL protectants->1.3.4 Prostaglandin analogues Misoprostol is not routinely used for GI indications. Cytotec protectants->1.3.4 Prostaglandin analogues->misoprostol

8 With diclofenac or naproxen protectants->1.3.4 Prostaglandin analogues->misoprostol ESOMEPRAZOLE inhibitors IV esomeprazoleshould only be prescribed in secondary care by or under the explicit direction of a specialist. Esomeprazole inhibitors->esomeprazole IV esomeprazoleshould only be prescribed in secondary care by or under the explicit direction of a specialist. Nexium inhibitors->esomeprazole IV esomeprazoleshould only be prescribed in secondary care by or under the explicit direction of a specialist. With naproxen inhibitors->esomeprazole LANSOPRAZOLE inhibitors Lansoprazole inhibitors->lansoprazole Zoton inhibitors->lansoprazole Prescribe generically OMEPRAZOLE inhibitors Parenteralomeprazole has not been approved for. Omeprazole inhibitors->omeprazole Parenteralomeprazole has not been approved for. Losec inhibitors->omeprazole Parenteralomeprazole has not been approved for. Prescribe generically With ketoprofen inhibitors->omeprazole PANTOPRAZOLE inhibitors Parenteral pantoprazoleshould only be prescribed in secondary care by or under the explicit direction of a specialist.

9 Pantoprazole inhibitors->pantoprazole Parenteral pantoprazoleshould only be prescribed in secondary care by or under the explicit direction of a specialist. Protium inhibitors->pantoprazole Prescribe generically. RABEPRAZOLE SODIUM inhibitors Rabeprazole inhibitors->rabeprazole SODIUM Pariet inhibitors->rabeprazole SODIUM Adsorbents and bulk-forming drugs 1.4 Acute diarrhoea KAOLIN, LIGHT 1.4 Acute diarrhoea->1.4.1 Adsorbents and bulk-forming drugs Kaolin Mixture, BP 1.4 Acute diarrhoea->1.4.1 Adsorbents and bulk-forming drugs->kaolin, LIGHT CODEINE PHOSPHATE 1.4 Acute diarrhoea->1.4.2 Antimotility drugs Preparations 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->codeine PHOSPHATE CO-PHENOTROPE 1.4 Acute diarrhoea->1.4.2 Antimotility drugs Co-phenotrope 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->co-phenotrope LOPERAMIDE HYDROCHLORIDE 1.4 Acute diarrhoea->1.4.2 Antimotility drugs Loperamide 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->loperamide HYDROCHLORIDE Imodium 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->loperamide HYDROCHLORIDE

10 Compound Imodium Plus MORPHINE Kaolin and Morphine Mixture, BP Enkephalinase inhibitors RACECADOTRIL Hidrasec TEDUGLUTIDE Revestive BALSALAZIDE SODIUM Colazide MESALAZINE Asacol Asacol MR Ipocol Mezavant XL None None None 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->loperamide HYDROCHLORIDE 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->loperamide HYDROCHLORIDE->Compound 1.4 Acute diarrhoea->1.4.2 Antimotility drugs 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->morphine 1.4 Acute diarrhoea 1.4 Acute diarrhoea->1.4.3 Enkephalinase inhibitors 1.4 Acute diarrhoea->1.4.3 Enkephalinase inhibitors->racecadotril 1.5 Chronic bowel disorders->short bowel syndrome 1.5 Chronic bowel disorders->short bowel syndrome->teduglutide Aminosalicylates Aminosalicylates->BALSALAZIDE SODIUM Aminosalicylates Aminosalicylates->MESALAZINE Aminosalicylates->MESALAZINE Aminosalicylates->MESALAZINE Aminosalicylates->MESALAZINE

11 Octasa Aminosalicylates->MESALAZINE Pentasa Aminosalicylates->MESALAZINE Pentasa granules are not approved for. Salofalk Aminosalicylates->MESALAZINE OLSALAZINE SODIUM Aminosalicylates Approved for distal colitis only. Dipentum Aminosalicylates->OLSALAZINE SODIUM Approved for distal colitis only. SULFASALAZINE Shared care guidelines Aminosalicylates A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over the agreed responsibilities including. Click here to access shared care guidelines. Sulfasalazine Shared care guidelines Aminosalicylates->SULFASALAZINE A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over the agreed responsibilities including. Click here to access shared care guidelines. Salazopyrin Shared care guidelines Aminosalicylates->SULFASALAZINE A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over the agreed responsibilities including. Click here to access shared care guidelines. BECLOMETASONE DIPROPIONATE Corticosteroids Clipper Corticosteroids->BECLOMETASONE DIPROPIONATE Second-line option (after prednisolone tablets) for the treatment of mild or moderate ulcerative colitis in active phase of left-sided or extensive UC, as add-on therapy to 5-ASA containing drugs in patients who are non-responders to 5-ASA therapy. Full 4 week therapy cycle must be prescribed by secondary care. BUDESONIDE Corticosteroids

12 Budenofalk Corticosteroids->BUDESONIDE Prescribe generically. Entocort Corticosteroids->BUDESONIDE Prescribe generically. HYDROCORTISONE Corticosteroids Colifoam Corticosteroids->HYDROCORTISONE PREDNISOLONE Corticosteroids Oral Corticosteroids->PREDNISOLONE Rectal Corticosteroids->PREDNISOLONE Prednisolone Corticosteroids->PREDNISOLONE->Rectal Predsol Corticosteroids->PREDNISOLONE->Rectal AZATHIOPRINE Shared care guidelines affecting the immune response A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over the agreed responsibilities including. Click here to access shared care guidelines. Preparations Shared care guidelines affecting the immune response->azathioprine A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over the agreed responsibilities including. Click here to access shared care guidelines. CICLOSPORIN affecting the immune response

13 Preparations affecting the immune response->ciclosporin Oral mercaptopurine for malignancyshould only be prescribed in secondary care by or under the explicit direction of a specialist. MERCAPTOPURINE Shared care guidelines affecting the immune response A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over the agreed responsibilities including. Click here to access shared care guidelines. Preparations Shared care guidelines affecting the immune response->mercaptopurine A Shared Care Guideline (SCG) may be available. Where it is, obtain guideline from secondary care and if happy to prescribe in accordance with the guidelines, take over the agreed responsibilities including. Click here to access shared care guidelines METHOTREXATE affecting the immune response Oral methotrexate for malignancy and parenteral methotrexate should only be prescribed in secondary care by or under the explicit direction of a specialist. Preparations affecting the immune response->methotrexate Oral methotrexate for malignancy and parenteral methotrexate should only be prescribed in secondary care by or under the explicit direction of a specialist. Cytokine modulators affecting the immune response ADALIMUMAB affecting the immune response->cytokine modulators TA329 ADALIMUMAB affecting the immune response->cytokine modulators TA187 Preparations affecting the immune response->cytokine modulators->adalimumab

14 INFLIXIMAB affecting the immune response->cytokine modulators TA329 TA 140, Infliximab is not recommended for the treatment of subacute manifestations of moderate to severe active ulcerative colitis that would normally be managed in an outpatient setting. INFLIXIMAB affecting the immune response->cytokine modulators TA187 TA 140, Infliximab is not recommended for the treatment of subacute manifestations of moderate to severe active ulcerative colitis that would normally be managed in an outpatient setting. INFLIXIMAB affecting the immune response->cytokine modulators TA163 TA 140, Infliximab is not recommended for the treatment of subacute manifestations of moderate to severe active ulcerative colitis that would normally be managed in an outpatient setting. GOLIMUMAB affecting the immune response->cytokine modulators TA329 Vedolizumab affecting the immune response VEDOLIZUMAB affecting the immune response->vedolizumab TA352 Entyvio affecting the immune response->vedolizumab->vedolizumab Food allergy 1.5 Chronic bowel disorders SODIUM CROMOGLICATE 1.5 Chronic bowel disorders->1.5.4 Food allergy Nalcrom 1.5 Chronic bowel disorders->1.5.4 Food allergy->sodium CROMOGLICATE ISPAGHULA HUSK 1.6 Laxatives->1.6.1 Bulk-forming laxatives Fybogel 1.6 Laxatives->1.6.1 Bulk-forming laxatives->ispaghula HUSK Ispagel Orange 1.6 Laxatives->1.6.1 Bulk-forming laxatives->ispaghula HUSK METHYLCELLULOSE 1.6 Laxatives->1.6.1 Bulk-forming laxatives

15 Celevac STERCULIA Normacol Normacol Plus BISACODYL Bisacodyl DANTRON With poloxamer 188 (as co-danthramer) Co-danthramer With docusate sodium (as co-danthrusate) Co-danthrusate DOCUSATE SODIUM Dioctyl Docusol Rectal 1.6 Laxatives->1.6.1 Bulk-forming laxatives->methylcellulose 1.6 Laxatives->1.6.1 Bulk-forming laxatives 1.6 Laxatives->1.6.1 Bulk-forming laxatives->sterculia 1.6 Laxatives->1.6.1 Bulk-forming laxatives->sterculia laxatives laxatives->bisacodyl laxatives laxatives->dantron laxatives->dantron->with poloxamer 188 (as co-danthramer) laxatives->dantron laxatives->dantron->with docusate sodium (as co-danthrusate) laxatives laxatives->docusate SODIUM laxatives->docusate SODIUM laxatives->docusate SODIUM

16 Norgalax Micro-enema GLYCEROL Glycerol Suppositories, BP SENNA Senna Manevac Senokot SODIUM PICOSULFATE Sodium Picosulfate Bowel cleansing Other stimulant laxatives ARACHIS OIL Arachis Oil Enema LIQUID PARAFFIN Liquid Paraffin Oral Emulsion, BP LACTULOSE laxatives->docusate SODIUM->Rectal laxatives laxatives->glycerol laxatives laxatives->senna laxatives->senna laxatives->senna laxatives laxatives->sodium PICOSULFATE laxatives->sodium PICOSULFATE laxatives 1.6 Laxatives->1.6.3 Faecal softeners 1.6 Laxatives->1.6.3 Faecal softeners->arachis OIL 1.6 Laxatives->1.6.3 Faecal softeners 1.6 Laxatives->1.6.3 Faecal softeners->liquid PARAFFIN laxatives

17 Lactulose MACROGOLS Macrogol Oral Powder, Compound Movicol Movicol -Half Movicol Paediatric laxatives->lactulose laxatives laxatives->macrogols laxatives->macrogols laxatives->macrogols laxatives->macrogols MAGNESIUM SALTS None laxatives Magnesium hydroxide Magnesium Hydroxide Mixture, BP Magnesium hydroxide with liquid paraffin Liquid Paraffin and Magnesium Hydroxide Oral Emulsion, BP Magnesium sulfate Magnesium Sulfate Bowel cleansing PHOSPHATES (RECTAL) Fleet Ready-to-use Enema laxatives->magnesium SALTS laxatives->magnesium SALTS->Magnesium hydroxide laxatives->magnesium SALTS laxatives->magnesium SALTS->Magnesium hydroxide with liquid paraffin laxatives->magnesium SALTS laxatives->magnesium SALTS->Magnesium sulfate laxatives->magnesium SALTS laxatives laxatives->phosphates (RECTAL)

18 Phosphates Enema BP Formula B SODIUM CITRATE (RECTAL) Micolette Micro-enema Micralax Micro-enema Relaxit Micro-enema MACROGOLS Klean-Prep Moviprep MAGNESIUM CITRATE Citramag PHOSPHATES (ORAL) OsmoPrep Fleet Phospho-soda SODIUM PICOSULFATE WITH MAGNESIUM CITRATE CitraFleet None laxatives->phosphates (RECTAL) laxatives laxatives->sodium CITRATE (RECTAL) laxatives->sodium CITRATE (RECTAL) laxatives->sodium CITRATE (RECTAL) 1.6 Laxatives->1.6.5 Bowel cleansing 1.6 Laxatives->1.6.5 Bowel cleansing ->MACROGOLS 1.6 Laxatives->1.6.5 Bowel cleansing ->MACROGOLS 1.6 Laxatives->1.6.5 Bowel cleansing 1.6 Laxatives->1.6.5 Bowel cleansing ->MAGNESIUM CITRATE 1.6 Laxatives->1.6.5 Bowel cleansing 1.6 Laxatives->1.6.5 Bowel cleansing ->PHOSPHATES (ORAL) 1.6 Laxatives->1.6.5 Bowel cleansing ->PHOSPHATES (ORAL) 1.6 Laxatives->1.6.5 Bowel cleansing 1.6 Laxatives->1.6.5 Bowel cleansing ->SODIUM PICOSULFATE WITH MAGNESIUM CITRATE

19 Picolax 1.6 Laxatives->1.6.5 Bowel cleansing ->SODIUM PICOSULFATE WITH MAGNESIUM CITRATE Peripheral opioid-receptor antagonists 1.6 Laxatives METHYLNALTREXONE BROMIDE 1.6 Laxatives->1.6.6 Peripheral opioid-receptor antagonists Relistor 1.6 Laxatives->1.6.6 Peripheral opioid-receptor antagonists->methylnaltrexone BROMIDE NALOXEGOL None 1.6 Laxatives->1.6.6 Peripheral opioid-receptor antagonists TA345 Moventig None 1.6 Laxatives->1.6.6 Peripheral opioid-receptor antagonists->naloxegol LINACLOTIDE 1.6 Laxatives->1.6.7 Other drugs used in constipation Constella 1.6 Laxatives->1.6.7 Other drugs used in constipation->linaclotide LUBIPROSTONE 1.6 Laxatives->1.6.7 Other drugs used in constipation TA318 Amitiza 1.6 Laxatives->1.6.7 Other drugs used in constipation->lubiprostone PRUCALOPRIDE 1.6 Laxatives->1.6.7 Other drugs used in constipation TA211 Resolor 1.6 Laxatives->1.6.7 Other drugs used in constipation->prucalopride Anugesic-HC 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids Anusol-HC 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids

20 Perinal Proctofoam HC Proctosedyl Scheriproct Ultraproct Uniroid-HC Xyloproct Rectal sclerosants PHENOL Oily Phenol Injection, BP GLYCERYL TRINITRATE Rectogesic 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids 1.7 Local for anal and rectal disorders->1.7.2 Compound haemorrhoidal with corticosteroids 1.7 Local for anal and rectal disorders 1.7 Local for anal and rectal disorders->1.7.3 Rectal sclerosants 1.7 Local for anal and rectal disorders->1.7.3 Rectal sclerosants->phenol 1.7 Local for anal and rectal disorders->1.7.4 Management of anal fissures 1.7 Local for anal and rectal disorders->1.7.4 Management of anal fissures->glyceryl TRINITRATE

21 CHOLIC ACID Orphacol URSODEOXYCHOLIC ACID Ursodeoxycholic Acid Destolit Ursofalk Ursogal Other for biliary disorders Rowachol Bile acid sequestrants COLESTYRAMINE None None secretions->1.9.1 Drugs affecting biliary composition and flow secretions->1.9.1 Drugs affecting biliary composition and flow->cholic ACID secretions->1.9.1 Drugs affecting biliary composition and flow secretions->1.9.1 Drugs affecting biliary composition and flow->ursodeoxycholic ACID secretions->1.9.1 Drugs affecting biliary composition and flow->ursodeoxycholic ACID secretions->1.9.1 Drugs affecting biliary composition and flow->ursodeoxycholic ACID secretions->1.9.1 Drugs affecting biliary composition and flow->ursodeoxycholic ACID secretions->1.9.1 Drugs affecting biliary composition and flow secretions->1.9.1 Drugs affecting biliary composition and flow->other for biliary disorders secretions secretions->1.9.2 Bile acid sequestrants

22 Preparations Aprotinin Pancreatin PANCREATIN Creon Creon Micro Pancrex Pancrex V Higher-strength Creon Creon Nutrizym 22 Pancrease HL secretions->1.9.2 Bile acid sequestrants->colestyramine secretions secretions secretions->1.9.4 Pancreatin secretions->1.9.4 Pancreatin->PANCREATIN secretions->1.9.4 Pancreatin->PANCREATIN secretions->1.9.4 Pancreatin->PANCREATIN secretions->1.9.4 Pancreatin->PANCREATIN secretions->1.9.4 Pancreatin->PANCREATIN secretions->1.9.4 Pancreatin->PANCREATIN->Higher-strength secretions->1.9.4 Pancreatin->PANCREATIN->Higher-strength secretions->1.9.4 Pancreatin->PANCREATIN->Higher-strength secretions->1.9.4 Pancreatin->PANCREATIN->Higher-strength

Report generated from MPH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed Formulary Status. TA Number.

Report generated from MPH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed Formulary Status. TA Number. Report generated from MPH provided by Complete (www.pharmpress.com). Accessed 15 01 2016 Title Status Section TA Number TA Link Alu-Cap simeticone->aluminium- and magnesium-containing antacids->aluminium

More information

1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->aluminium-magnesium complexes->hydrotalcite->with simeticone

1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->aluminium-magnesium complexes->hydrotalcite->with simeticone Report generated from BNF - Local Information provided by FormularyComplete (www.pharmpress.com). Accessed 28 07 2017 Title Formulary Status Section Acidex 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.2

More information

GASTRO-INTESTINAL SYSTEM 1.1 Dyspepsia and gastro-oesophageal reflux disease

GASTRO-INTESTINAL SYSTEM 1.1 Dyspepsia and gastro-oesophageal reflux disease Original Date of issue: 05/04/07 Last eviewed: 08/03/2013 Version: 5 Page 1 of 11 GASTO-INTESTINAL SYSTEM 1.1 Dyspepsia and gastro-oesophageal reflux disease 1.1.1 Antacids and simeticone Magnesium Trisilicate

More information

Chapter 1 Gastro-Intestinal System

Chapter 1 Gastro-Intestinal System Chapter 1 page number 1 Chapter 1 Gastro-Intestinal System First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary

More information

Chapter 1 Gastro-Intestinal System

Chapter 1 Gastro-Intestinal System Chapter 1 page number 1 Chapter 1 Gastro-Intestinal System First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary

More information

1. Gastro-intestinal system

1. Gastro-intestinal system 1. Gastro-intestinal system Also see Appendix 1B Guidance on Management of Dyspepsia http://www.fifeadtc.scot.nhs.uk/formulary/1-gastro-intestinal/appendix-1b-management-ofdyspepsia.aspx Also see SIGN

More information

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM. 1 April 13

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM. 1 April 13 BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM 1 BNF 1.1 ANTACIDS Mucogel and Peptac are effective antacids and are available over the counter Gaviscon / Gaviscon Advance are available over the counter First

More information

BNF CHAPTER 1: GASTROINTESTINAL

BNF CHAPTER 1: GASTROINTESTINAL BNF CHAPTER 1: GASTROINTESTINAL 1.1 DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE For symptomatic relief of hyperacidity, peptic ulcers, oesophagitis and acid reflux, liquids usually act faster than

More information

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM 1 ANTACIDS Maalox and Peptac are effective antacids that can be bought Over the Counter for self-limiting symptoms. Choice Product Cost Effective Options &Comments

More information

Gastrointestinal system

Gastrointestinal system Gastrointestinal system Medicines Formulary Contents: 1. Dyspepsia and gastro-oesophageal disease 1 2. Acute gastrointestinal bleeding 2 3. Irritable bowel syndrome 3 4. Diarrhoea 3 5. Inflammatory bowel

More information

BNF/BNFC Chapter 1 Gastro-intestinal System

BNF/BNFC Chapter 1 Gastro-intestinal System NF/NF hapter 1 Gastro-intestinal System irections for questions 1 to 10. ach of the questions or incomplete statements in this section is followed by five suggested answers. Select the best answer in each

More information

1 Gastro-intestinal system

1 Gastro-intestinal system Recommendations from the Lothian Formulary Committee (FC) following Scottish Medicines Consortium (SMC) advice, NICE MTA advice, (FAF3) unlicensed and off-label medicines and (FAF2) medicines not considered

More information

Objectives Brand name Generic name Primary indication, drug classes Dosage forms Patient counseling information Important side effects and contraindic

Objectives Brand name Generic name Primary indication, drug classes Dosage forms Patient counseling information Important side effects and contraindic laxatives Hawler medical university Collage of pharmacy/ fourth stage /pharmacy practice Sham A. Talat Shareef (B.Sc. Msc. clinical pharmacy) 2017-2018 Sham_talat@yahoo.com Head of Department Of Clinical

More information

1 Gastro-intestinal system

1 Gastro-intestinal system Recommendations from the Lothian Formulary Committee (FC) following Scottish Medicines Consortium (SMC) advice, NICE MTA advice, (FAF3) unlicensed and off-label medicines and (FAF2) medicines not considered

More information

ASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER

ASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER European Medicines Agency Evaluation of Medicines for Human Use London, October 2007 Doc. Ref. EMEA/527934/2007 ASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER The Paediatric Working Party

More information

Second term/

Second term/ Second term/ 2015-2016 L. 1 Dr Mohammed AL-Zobaidy Learning objectives GIT pharmacology After completing this chapter the student will be able to: Recognise pathophysiological factors implicated in acid-peptic

More information

Constipation. What is constipation? What causes constipation? How common is constipation?

Constipation. What is constipation? What causes constipation? How common is constipation? Constipation What is constipation? Constipation is the word we use to describe any difficulty having a bowel movement. This does not just mean infrequent bowel movements, (two or fewer bowel movements

More information

Sandwell and West Birmingham Hospitals NHS Trust

Sandwell and West Birmingham Hospitals NHS Trust Sandwell and West Birmingham Hospitals NHS Trust Sandwell and West Birmingham Clinical Commissioning Group The drugs contained in the formulary of Sandwell and West Birmingham Hospitals Trust are listed

More information

MCA Training Made Easy

MCA Training Made Easy MCA Training Made Easy MODULE 8 Indigestion and Bowel Problems Learning objectives After reading this module you will: Understand the symptoms and causes of indigestion and heartburn and how to treat them

More information

Gateshead Primary Care Formulary Incorporating Gateshead Medicines Management Committee, Gateshead NHS Foundation Trust and North of Tyne Area

Gateshead Primary Care Formulary Incorporating Gateshead Medicines Management Committee, Gateshead NHS Foundation Trust and North of Tyne Area Gateshead Primary Care Formulary Incorporating Gateshead Medicines Management Committee, Gateshead NHS Foundation Trust and North of Tyne Area Prescribing Committee formulary decisions Prepared by Pharmicus

More information

PHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE

PHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE PHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE Definition A circumscribed ulceration of the gastrointestinal mucosa occurring in areas exposed to acid and pepsin and most often caused

More information

A. Incorrect! Histamine is a secretagogue for stomach acid, but this is not the only correct answer.

A. Incorrect! Histamine is a secretagogue for stomach acid, but this is not the only correct answer. Pharmacology - Problem Drill 21: Drugs Used To Treat GI Disorders No. 1 of 10 1. Endogenous secretagogues for stomach acid include: #01 (A) Histamine (B) Gastrin (C) PGE1 (D) A and B (E) A, B and C Histamine

More information

Pharmacology. Drugs that Affect the Gastrointestinal System

Pharmacology. Drugs that Affect the Gastrointestinal System Pharmacology Drugs that Affect the Gastrointestinal System Topics Peptic Ulcer Disease Constipation Diarrhea Emesis Digestion Peptic Ulcer Disease Factors that Increase Acidity Factors that Protect Against

More information

Doncaster & Bassetlaw Medicines Formulary

Doncaster & Bassetlaw Medicines Formulary Doncaster & Bassetlaw Medicines Formulary Section 1.5 Chronic Bowel Disorders (including IBD) Aminosalicylates: Mesalazine 400mg and 800mg MR Tablets (Octasa) Mesalazine 1.2g MR Tablets (Mezavant XL) Mesalazine

More information

Gastro-intestinal system Dyspep&Gastro-Oesophageal Reflux Disease Other Drugs for Dyspepsia and GORD

Gastro-intestinal system Dyspep&Gastro-Oesophageal Reflux Disease Other Drugs for Dyspepsia and GORD Formulary Book : Contents Subparagraph Page Nbr. 1.1.2.1 Gastro-intestinal system Dyspep&Gastro-Oesophageal Reflux Disease Other Drugs for Dyspepsia and GORD 1.2 Gastro-intestinal system Antispasmod.&Other

More information

.Drugs and the gastrointestinal system. Control of gastric acid secretion Gastric acid-related conditions. Clinical sketch.

.Drugs and the gastrointestinal system. Control of gastric acid secretion Gastric acid-related conditions. Clinical sketch. .Drugs and the gastrointestinal system Chapter 11 11.1 Gastric acid-related conditions 149 11.2 Nausea and vomiting 153 11.3 Disorders of the bowel 155 11.4 Gallstones 156 Self-assessment on Chapter 11:

More information

Gateshead Formulary. Adapted with thanks from Formulary document prepared by Pharmicus

Gateshead Formulary. Adapted with thanks from Formulary document prepared by Pharmicus Gateshead Formulary Incorporating Gateshead Medicines Management Committee, Gateshead NHS Foundation Trust and North of Tyne Area Prescribing Committee formulary decisions Adapted with thanks from Formulary

More information

Dyspepsia. Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea.

Dyspepsia. Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea. Antacids Hawler medical university Collage of pharmacy/ fourth year /pharmacy practice Sham A. Talat Shareef (B.Sc. Msc. clinical pharmacy) 2017-2018 Sham_talat@yahoo.com Head of Department Of Clinical

More information

Report generated from BNF - NNUH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed

Report generated from BNF - NNUH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed Report generated from BNF - NNUH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed 24 11 2017 This is a live document. Changes may have been made to the formulary since this report

More information

Medical therapies and IBD

Medical therapies and IBD Medical therapies and IBD Although there is no cure for IBD, there are many treatment options available. There is no standard treatment for IBD that is effective in all situations or for all patients,

More information

Care at the Chemist. Formulary

Care at the Chemist. Formulary Care at the Chemist Formulary 1 Acute bacterial conjunctivitis Chloramphenicol 0.5% eye drops (10ml) For ages 2 years and over. Chloramphenicol 1% eye oint. (4g) For ages 2 years and over. Allergy Loratadine

More information

Primary Care Constipation Guidelines. Version 1 November 2016

Primary Care Constipation Guidelines. Version 1 November 2016 Primary Care Constipation Guidelines Version 1 November 2016 VERSION CONTROL Version Date Amendments made Version 1 November 2016 New guideline Contents 1. Management of constipation in adults: acute and

More information

Lab:2 Drugs acting on Gastrointestinal tract

Lab:2 Drugs acting on Gastrointestinal tract Lab:2 Drugs acting on Gastrointestinal tract Drugs that used to treat three common medical conditions involving the gastrointestinal tract: peptic ulcers and gastroesophageal reflux disease (GERD), chemotherapy-induced

More information

Examples of prices, license restrictions and availability of common over the counter medications.

Examples of prices, license restrictions and availability of common over the counter medications. Examples of s, license restrictions and availability of common over the counter medications. GSL items can be purchased from any er. Supermarkets and discount stores may be more cost effective than pharmacies.

More information

Care at the Chemist. Formulary

Care at the Chemist. Formulary Care at the Chemist Formulary 1 Acute bacterial conjunctivitis Chloramphenicol 0.5% eye drops (10ml) Chloramphenicol 1% eye oint. (4g) Allergy Loratadine 10mg tablets (7) Sodium cromoglycate 2% eye drops

More information

SELF CARE AND OTC MEDICINES ON PRESCRIPTION

SELF CARE AND OTC MEDICINES ON PRESCRIPTION 306 Medical Centre: SELF CARE AND OTC MEDICINES ON PRESCRIPTION NHS Southwark CCG no longer supports the routine prescribing on the NHS of medications for short term illnesses and minor conditions and

More information

Constipation an Old Friend. Presented by Dr. Keith Harris

Constipation an Old Friend. Presented by Dr. Keith Harris Constipation an Old Friend Presented by Dr. Keith Harris Irregularity and the Tricks of the Trade." CONSTIPATION What is constipation? INFREQUENT BOWEL MOVEMENTS DIFFICULTY DURING DEFECATION SENSATION

More information

3.4 gram/7 gram powder -- $5.63

3.4 gram/7 gram powder -- $5.63 MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Bowel Movements P&T DATE: 9/11/2018 CLASS: Gastrointestinal Disorders REVIEW HISTORY: 12/16, 9/15, 9/12, 5/08 LOB: MCL (MONTH/YEAR)

More information

Antidiarrheals Antidiarrheal

Antidiarrheals Antidiarrheal Antidiarrheals Major factors in diarrhea Increased motility of the GI tract. Decreased absorption of fluid. Antidiarrheal drugs include: Antimotility agents. Adsorbents. Drugs that modify fluid and electrolyte

More information

Frequently Asked Questions Specific Medications

Frequently Asked Questions Specific Medications Medications to control inflammation are the single most important means of treating IBD. By bringing the inflammation under control, medications can relieve the symptoms of IBD and reduce the chances of

More information

Dr. Elmer Schabel, MD. Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany (No conflicts of interest)

Dr. Elmer Schabel, MD. Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany (No conflicts of interest) EMA workshop on the development of new medicinal products for the treatment of ulcerative colitis and Crohn s disease Overview of authorised medicines for IBD in Europe - previous regulatory positions

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 20 October 2010

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 20 October 2010 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 20 October 2010 MEZAVANT LP 1200 mg, prolonged-release gastro-resistant tablets B/60 (CIP code: 378 689-2) Applicant

More information

Laxative Policy THIS POLICY MUST BE READILY ACCESSIBLE AT ALL TIMES AND AT THE POINT WHERE MEDICINES ARE USED.

Laxative Policy THIS POLICY MUST BE READILY ACCESSIBLE AT ALL TIMES AND AT THE POINT WHERE MEDICINES ARE USED. Laxative Policy This is a working document and any changes that become necessary to this policy must be notified in writing to the Medicine Management Group via the Chief Pharmacist, East Cheshire Trust

More information

Gastrointestinal Pharmacology

Gastrointestinal Pharmacology Gastrointestinal Pharmacology Jan Kehr Department of Physiology and Pharmacology Gastrointestinal Pharmacology v Background v Peptic disorders v Constipation and Diarrhea v Chronic Bowel Disease Gastrointestinal

More information

Managing constipation in adults with co-morbidities

Managing constipation in adults with co-morbidities Managing constipation in adults with co-morbidities Angela Gardiner and Andrea Hilton Constipation can be described in a number of ways but in general it is related to straining, reduced frequency of defecation

More information

High Resolution Oesophageal Manometry and 24 hour ph Monitoring. Information for patients

High Resolution Oesophageal Manometry and 24 hour ph Monitoring. Information for patients High Resolution Oesophageal Manometry and 24 hour ph Monitoring Information for patients A request has been sent to the GI Physiology Department to book an appointment for you to come to the Churchill

More information

New treatment options in UC. Rob Bryant IBD Consultant Royal Adelaide Hospital

New treatment options in UC. Rob Bryant IBD Consultant Royal Adelaide Hospital New treatment options in UC Rob Bryant IBD Consultant Royal Adelaide Hospital Talk Outline 1. Raising expectations 2. Optimising UC therapy 3. Clinical trials 4. What s new on the PBS? 5. Questions 1.

More information

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D Gastro-oesophageal reflux disease and peptic ulcer disease By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D Gastro-oesophageal reflux disease and peptic ulcer disease Learning objectives:

More information

The management of constipation in adults

The management of constipation in adults The management of constipation in adults Angela Gardiner and Andrea Hilton Abstract Definitions of constipation vary, but in general are related to straining at stool, reduced frequency of defecation and/or

More information

Guidelines for the Management of Constipation: Adult Patients

Guidelines for the Management of Constipation: Adult Patients Guidelines for the Management of Constipation: Adult Patients This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the circumstances

More information

Gastro-intestinal System

Gastro-intestinal System CHAPTER 1 GASTRO-INTESTINAL SYSTEM 1.1 Nil by mouth patients drug administration Patients for investigations e.g. OGD (endoscopy): administer usual medicines with a sip of water caution with medicines

More information

North West London Integrated Formulary

North West London Integrated Formulary North West London Integrated Formulary PUBLISHED VERSION (v15 02.04.2015) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended

More information

Protectives and Adsorbents. Inorganic chemistry Course 1 Third year Assist. Lecturer Ahlam A. Shafeeq MSc. Pharmaceutical chemistry

Protectives and Adsorbents. Inorganic chemistry Course 1 Third year Assist. Lecturer Ahlam A. Shafeeq MSc. Pharmaceutical chemistry Protectives and Adsorbents Inorganic chemistry Course 1 Third year 2016-2017 Assist. Lecturer Ahlam A. Shafeeq MSc. Pharmaceutical chemistry Protectives and Adsorbents This group of gastrointestinal agents

More information

Opioid constipation treatment dulcolax

Opioid constipation treatment dulcolax P ford residence southampton, ny Opioid constipation treatment dulcolax Posts about how to relieve constipation instantly written by gbrese1958. Official Web site for MOVANTIK (naloxegol) tablets, for

More information

Aminosalicylates in Inflammatory Bowel Disease in Adults (Review date: July 2020) Page 1

Aminosalicylates in Inflammatory Bowel Disease in Adults (Review date: July 2020) Page 1 Full Title of Guideline: Author (include email and role): Aminosalicylates in Inflammatory Bowel Disease in Adults Natalie Tse- Senior Clinical Pharmacist (natalie.tse@nuh.nhs.uk) Dr. Nina Lewis- Consultant

More information

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers

More information

Chapter 5 Gastroenterology. Dose. Route. Units. Given. Dose. Route. Units. Given

Chapter 5 Gastroenterology. Dose. Route. Units. Given. Dose. Route. Units. Given Chapter 5 Gastroenterology Georgia Woodfield TERLIPRESSIN CIPROFLOXACIN 2 initial dose 500 Every 4 hours until bleeding controlled can be reduced to 1 after initial dose if side effects develop or if patient

More information

Cambridgeshire Community Pharmacy Minor Ailments Service. February 2009

Cambridgeshire Community Pharmacy Minor Ailments Service. February 2009 Cambridgeshire Community Pharmacy Minor Ailments Service February 2009 Contents 3 Constipation & Paediatric Constipation 4 Diarrhoea & Paediatric Diarrhoea 5 Indigestion & Infant Gripes/Colic/Wind 6 Hay

More information

Mosby items and derived items 2005, 2002 by Mosby, Inc. 1 Mosby items and derived items 2005, 2002 by Mosby, Inc. 2

Mosby items and derived items 2005, 2002 by Mosby, Inc. 1 Mosby items and derived items 2005, 2002 by Mosby, Inc. 2 CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN Types of Acid-Controlling Agents Antacids H 2 antagonists Proton pump inhibitors Mosby items and derived items 2005,

More information

Inflammatory bowel disease. Kawa Obeid, PhD

Inflammatory bowel disease. Kawa Obeid, PhD Inflammatory bowel disease Kawa Obeid, PhD 63 Introduction Inflammatory bowel disease (IBD) can be divided into two chronic inflammatory disorders of the gastro- intestinal tract, namely Crohn's disease

More information

Copy right protected Page 1

Copy right protected Page 1 DRUGS USED IN ULCERS AND GIT DISORDERS A peptic ulcer, also known as PUD or peptic ulcer disease is an ulcer of an area of the gastrointestinal tract that is usually acidic and thus extremely painful.

More information

National Institute for Health and Care Excellence

National Institute for Health and Care Excellence National Institute for Health and Care Excellence 4-year surveillance (2017) Ulcerative colitis: management (2013) NICE guideline CG166 Appendix A.2: Summary of new evidence from surveillance Patient information

More information

North West London Integrated Formulary

North West London Integrated Formulary North West London Integrated Formulary PUBLISHED VERSION (v14 05.02.2015) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended

More information

North West London Integrated Formulary

North West London Integrated Formulary North West London Integrated Formulary PUBLISHED VERSION (v19 19.11.2015) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended

More information

Primary & Secondary Care Inflammatory Bowel Disease Pathway February 2018

Primary & Secondary Care Inflammatory Bowel Disease Pathway February 2018 South East London Area Prescribing Committee: Primary & Secondary Care Inflammatory Bowel Disease Pathway February 2018 Developed by: South East London IBD Pathway Development Group Approved: February

More information

MEDICAL TERMS USED IN IBD

MEDICAL TERMS USED IN IBD INFORMATION SHEET MEDICAL TERMS USED IN IBD INTRODUCTION You are likely to come across many new terms when you are diagnosed with Inflammatory. Bowel Disease. This information sheet explains some of the

More information

What Is Constipation?

What Is Constipation? CONSTIPATION What Is Constipation? Constipation is when you have infrequent or hard-to-pass bowel movements (meaning they are painful or you have to strain), have hard stools or feel like your bowel movements

More information

ABC of palliative care: Constipation and diarrhoea

ABC of palliative care: Constipation and diarrhoea BMJ 1997;315:1293-1296 (15 November) Clinical review ABC of palliative care: Constipation and diarrhoea Marie Fallon, Bill O'Neill Prevalence of constipation Top Prevalence of constipation Assessment of

More information

DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM

DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM Page 1 DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM SUNALI MEHTA Histamines and antihistamines: Histamine means tissue amine and is present in ample amount in the lung, skin and GI tract mucosa. Mast cells,

More information

TA Number. TA Link. Annotation

TA Number. TA Link. Annotation Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation Anti-infective preparations Anti-inflammatory

More information

Treat primary. symptoms. Offer general lifestyle advice. Manage IBS according to the dominant symptom. Follow up. Symptoms do not improve

Treat primary. symptoms. Offer general lifestyle advice. Manage IBS according to the dominant symptom. Follow up. Symptoms do not improve Treat primary symptoms Background information for clinicians Offer general lifestyle advice Background information for patients Manage IBS according to the dominant symptom Provenance Psychological symptoms

More information

Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control

Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control Erin Zimny, MD Emergency Medicine Hospice and Palliative Medicine Henry Ford Hospital Disclosures I do NOT have any financial

More information

Current management options and recent advances in IBD

Current management options and recent advances in IBD n DRUG REVIEW Current management options and recent advances in IBD Ben Warner BSc, MRCP and Peter Irving MA, MD, FRCP SPL The advent of biological therapies has revolutionised the management of inflammatory

More information

Oesophageal Manometry and 24 hour ph monitoring A guide to the test

Oesophageal Manometry and 24 hour ph monitoring A guide to the test n The Leeds Teaching Hospitals NHS Trust Oesophageal Manometry and 24 hour ph monitoring A guide to the test Information for patients This leaflet is intended to answer some of the questions you may have

More information

Drugs Affecting the Gastrointestinal System. Antacids, Constipation, Increasing gastrointestinal motility

Drugs Affecting the Gastrointestinal System. Antacids, Constipation, Increasing gastrointestinal motility Drugs Affecting the Gastrointestinal System Antacids, Constipation, Increasing gastrointestinal motility Cells of the Gastric Gland parietal cells: produce & secrete HCl primary site of action for many

More information

daily; available as 10- mg g PO

daily; available as 10- mg g PO Overview of the PRN: The Pain and Palliative Care PRN of ACCP is an organization of pharmacy practitioners, clinical scientists, pharmacy educators, and others. Its mission is to advance pain and palliative

More information

Peptic ulcer disease Disorders of the esophagus

Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Burning epigastric pain Exacerbated by fasting Improved with meals Ulcer: disruption of mucosal integrity >5 mm in size, with depth

More information

North West London Integrated Formulary

North West London Integrated Formulary North West London Integrated Formulary PUBLISHED VERSION (v28 23.04.2018) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended

More information

This is an electronic version of the Palliative Medicine Handbook 3rd edition, produced in PDF (portable document file) format.

This is an electronic version of the Palliative Medicine Handbook 3rd edition, produced in PDF (portable document file) format. This is an electronic version of the Palliative Medicine Handbook 3rd edition, produced in PDF (portable document file) format. Part or all of this document may be printed from this file and distributed

More information

North West London Integrated Formulary

North West London Integrated Formulary North West London Integrated Formulary PUBLISHED VERSION (v20 23.2.2016) The Integrated Formulary (IF) is a list of medicines for adult patients and is for use in North West London. The IF is intended

More information

Crohn s Disease. How does Crohn s disease affect the intestinal tract?

Crohn s Disease. How does Crohn s disease affect the intestinal tract? Crohn s Disease Crohn s disease is one of the two main forms of inflammatory bowel disease (IBD). The second main form of inflammatory bowel disease is ulcerative colitis. Crohn s disease causes inflammation

More information

Garrick Brown, MD. Digestive Health Specialists Tacoma Gig Harbor

Garrick Brown, MD. Digestive Health Specialists Tacoma Gig Harbor Garrick Brown, MD Digestive Health Specialists Tacoma Gig Harbor Today s Objectives Define IBD, its potential causes and diagnosis Discuss management and treatment Discuss complementary and alternative

More information

Drugs Affecting the Gastrointestinal System. Antidiarrheal and Laxatives

Drugs Affecting the Gastrointestinal System. Antidiarrheal and Laxatives Drugs Affecting the Gastrointestinal System Antidiarrheal and Laxatives Diarrhea Abnormal frequent passage of loose stools or Abnormal passage of stools with increased frequency, fluidity, and weight,

More information

Protocol to support reducing the use of and the effective use of laxatives. HaRD CCG employed Pharmacists and Medicines Optimisation Technicians.

Protocol to support reducing the use of and the effective use of laxatives. HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. NY&AWC Medicines Management Team Protocol to support reducing the use of and the effective use of laxatives Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols

More information

Patient information. Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4

Patient information. Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4 Patient information Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4 You have been diagnosed with laryngopharyngeal reflux (LPR), otherwise known as extra-oesophageal reflux

More information

Page 1 of 5 Official reprint from UpToDate www.uptodate.com 2017 UpToDate Patient education: Acid reflux (gastroesophageal reflux disease) in adults (The Basics) Written by the doctors and editors at UpToDate

More information

Formulary. 12 th Edition. Version14.1. May Eleanore Atkinson Medicines Information Pharmacist. Drug and Therapeutics Committee

Formulary. 12 th Edition. Version14.1. May Eleanore Atkinson Medicines Information Pharmacist. Drug and Therapeutics Committee Drug and Therapeutics Committee Formulary 12 th Edition Version14.1 May 2015 Compiled on behalf of the Drug and Therapeutics Committee by Eleanore Atkinson Medicines Information Pharmacist Formulary 12

More information

Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome (IBS) Irritable Bowel Syndrome (IBS) Dr Rex J Polson 17 th January 2018 Overview Description of the condition Discussion of symptoms and investigations that may be required Discussion of management and treatment

More information

Infliximab (Remicade) for paediatric ulcerative colitis - second line

Infliximab (Remicade) for paediatric ulcerative colitis - second line Infliximab (Remicade) for paediatric ulcerative colitis - second line September 2011 This technology summary is based on information available at the time of research and a limited literature search. It

More information

24 Hour Ambulatory Impedance and ph Study. An information guide

24 Hour Ambulatory Impedance and ph Study. An information guide TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION 24 Hour Ambulatory Impedance and ph Study An information guide 24 Hour Ambulatory Impedance and ph Study IMPORTANT!! Please read section

More information

Gastrointestinal Involvement in Adult Mitochondrial Disease

Gastrointestinal Involvement in Adult Mitochondrial Disease Newcastle Mitochondrial Disease Guidelines At a glance guidelines: Gastrointestinal Involvement in Adult Mitochondrial Disease For full guideline visit: http://www.newcastle-mitochondria.com/service/patient-care-guidelines/

More information

IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital

IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital Aims To understand the aetiology of IBD To understand the impact that

More information

CENTENE PHARMACY AND THERAPEUTICS DRUG REVIEW 3Q17 July August

CENTENE PHARMACY AND THERAPEUTICS DRUG REVIEW 3Q17 July August BRAND NAME Symproic GENERIC NAME Naldemedine MANUFACTURER Shionogi Inc. DATE OF APPROVAL March 23, 2017 PRODUCT LAUNCH DATE Anticipated to launch mid-summer 2017 REVIEW TYPE Review type 1 (RT1): New Drug

More information

Efficacy and Safety of Lubiprostone. Laura Wozniak February 23, 2010 K30 Monthly Journal Club

Efficacy and Safety of Lubiprostone. Laura Wozniak February 23, 2010 K30 Monthly Journal Club Efficacy and Safety of Lubiprostone Laura Wozniak February 23, 2010 K30 Monthly Journal Club Objectives Brief overview of constipation Review of article Discussion Constipation in Children 3-5% of all

More information

Medications. A: Specific medications

Medications. A: Specific medications Medications This section describes the medications used in IBD, how they work, when they are used and their more common and important side-effects. The list of side-effects is not all inclusive. If you

More information

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers This formulary is current as of February 11, 2010. Important Notes: Pharmacists must submit a claim on PharmaNet at the time

More information

MAS Formulary Products

MAS Formulary Products Ibuprofen Susp.100mg/5ml for pain and inflammation 100ml Care Ibuprofen Tabs 200mg for pain and inflammation 24 Care ( Added Jan 2016) Ibuprofen Tabs 400mg for pain and inflammation 24 Tariff price - P

More information